Translate
Anbio Biotechnology Class A Ordinary Shares
About
Anbio Biotechnology Class A Ordinary Shares (NASDAQ:NNNN) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 17 2026
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
Oct 9 2025
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025
Aug 8 2025
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
May 15 2025
Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions
Feb 20 2025
Anbio Biotechnology Announces Closing of Initial Public Offering
Financials
Revenue
$6.92 M
Market Cap
$1.15 B
P/E Ratio
435.75
EPS
0.06